Patents Assigned to Latitude Pharmaceuticals Inc.
-
Patent number: 10888616Abstract: This invention relates to ready-to-use and safe solution compositions of glucagon suitable for administration by manual injection or by an insulin pump or other injection device to treat hypoglycemia. Said compositions comprise glucagon, an acid, anti-gelling polyol, a stabilizing-salt, viscosity reducer and an antioxidant, have a final pH between about 2 and 5, and is gel-free, chemically-stable, and pump-able.Type: GrantFiled: February 22, 2018Date of Patent: January 12, 2021Assignee: LATITUDE PHARMACEUTICALS, INC.Inventors: Hailiang Chen, Andrew Xian Chen, Norman Keith Orida
-
Patent number: 10376560Abstract: This invention relates to aqueous solution compositions of vancomycin that are stable, ready for use and do not require reconstitution.Type: GrantFiled: July 13, 2017Date of Patent: August 13, 2019Assignee: LATITUDE PHARMACEUTICALS, INC.Inventor: Andrew Xian Chen
-
Patent number: 10369101Abstract: The present application provides parenteral compositions of diclofenac or its pharmaceutically acceptable salt and methods for making and using such compositions. Some of the compositions of the present application has one or more following properties: (1) ready to be injectable, (2) in the form of an oil-in-water emulsion, (3) stable under appropriate storage conditions, (4) containing therapeutically effective amount of diclofenac or its pharmaceutically acceptable salt, (5) sterilizable by filtration (6) containing components acceptable by regulatory agencies (e.g. the FDA), (7) containing low oil content and thus not exacerbating hyerlipidemia, and (8) is neither hyperallergenic nor vein irritating.Type: GrantFiled: March 17, 2014Date of Patent: August 6, 2019Assignee: LATITUDE PHARMACEUTICALS INC.Inventors: Franklin Okumu, Andrew X. Chen, Hailiang Chen
-
Patent number: 10238717Abstract: This invention relates to compositions of glucagon suitable for administration by manual injection or by an insulin pump or other injection device to treat hypoglycemia. Said compositions comprise glucagon and a sugar, have a final pH between about 1.5 and 3, and are gel-free, chemically-stable at body temperature and pump-able.Type: GrantFiled: March 30, 2017Date of Patent: March 26, 2019Assignee: LATITUDE PHARMACEUTICALS, INC.Inventor: Andrew Chen
-
Publication number: 20180236079Abstract: This invention relates to ready-to-use and safe solution compositions of glucagon suitable for administration by manual injection or by an insulin pump or other injection device to treat hypoglycemia. Said compositions comprise glucagon, an acid, anti-gelling polyol, a stabilizing-salt, viscosity reducer and an antioxidant, have a final pH between about 2 and 5, and is gel-free, chemically-stable, and pump-able.Type: ApplicationFiled: February 22, 2018Publication date: August 23, 2018Applicant: Latitude Pharmaceuticals, Inc.Inventors: Hailiang CHEN, Andrew Xian CHEN, Norman Keith ORIDA
-
Publication number: 20170304396Abstract: This invention relates to aqueous solution compositions of vancomycin that are stable, ready for use and do not require reconstitution.Type: ApplicationFiled: July 13, 2017Publication date: October 26, 2017Applicant: LATITUDE PHARMACEUTICALS, INC.Inventor: ANDREW XIAN CHEN
-
Publication number: 20170202926Abstract: This invention relates to compositions of glucagon suitable for administration by manual injection or by an insulin pump or other injection device to treat hypoglycemia. Said compositions comprise glucagon and a sugar, have a final pH between about 1.5 and 3, and are gel-free, chemically-stable at body temperature and pump-able.Type: ApplicationFiled: March 30, 2017Publication date: July 20, 2017Applicant: Latitude Pharmaceuticals, Inc.Inventor: Andrew Chen
-
Publication number: 20170189532Abstract: The present invention is directed to compositions and methods of preparation of phospholipid depots that are injectable through a fine needle.Type: ApplicationFiled: October 28, 2016Publication date: July 6, 2017Applicant: Latitude Pharmaceuticals Inc.Inventors: Andrew Xian Chen, Hailiang Chen
-
Patent number: 9517202Abstract: The present invention is directed to phospholipid compositions and methods of preparation of phospholipid depots that are injectable through a fine needle. The phospholipid depots prepared by the methods described herein comprise nanometer-sized phospholipid particles and exhibit a higher degree of structural order compared to compositions prepared by other methods.Type: GrantFiled: June 14, 2012Date of Patent: December 13, 2016Assignee: LATITUDE PHARMACEUTICALS INC.Inventors: Andrew Xian Chen, Hailiang Chen
-
Patent number: 9370486Abstract: In certain embodiments, this invention sets forth compositions, methods, and uses regarding a nanoemulsion composition that comprises a fat-soluble vitamin K and can therapeutically replace Phytonadione Injectable Emulsion, USP.Type: GrantFiled: November 28, 2012Date of Patent: June 21, 2016Assignee: LATITUDE PHARMACEUTICALS INC.Inventor: Andrew Xian Chen
-
Publication number: 20130189316Abstract: In certain embodiments, this invention sets forth compositions, methods, and uses regarding a nanoemulsion composition that comprises a fat-soluble vitamin K and can therapeutically replace Phytonadione Injectable Emulsion, USP.Type: ApplicationFiled: November 28, 2012Publication date: July 25, 2013Applicant: Latitude Pharmaceuticals Inc.Inventor: Latitude Pharmaceuticals Inc.
-
Publication number: 20120316108Abstract: The present invention is directed to compositions and methods of preparation of phospholipid depots that are injectable through a fine needle.Type: ApplicationFiled: June 14, 2012Publication date: December 13, 2012Applicant: Latitude Pharmaceuticals Inc.Inventors: Andrew Xian Chen, Hailiang Chen